[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

EMEA (Europe, Middle East and Africa) Subunit Vaccine Market Report 2017

December 2017 | 101 pages | ID: E995EE6C391EN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the EMEA Subunit Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Subunit Vaccine for these regions, from 2012 to 2022 (forecast)
  • Europe: Germany, France, UK, Russia, Italy and Benelux;
  • Middle East: Saudi Arabia, Israel, UAE and Iran;
  • Africa: South Africa, Nigeria, Egypt and Algeria.
EMEA Subunit Vaccine market competition by top manufacturers/players, with Subunit Vaccine sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
  • GE Healthcare Life Sciences
  • GSK
  • Reber Genetics
  • Merck
  • Sanofi
  • Virbac
  • Shenzhen Kangtai Biological Products
On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
  • Live Attenuated Vaccine
  • Inactivated Vaccine
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Hospital
  • Clinics
  • Public Services
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
EMEA (Europe, Middle East and Africa) Subunit Vaccine Market Report 2017

1 SUBUNIT VACCINE OVERVIEW

1.1 Product Overview and Scope of Subunit Vaccine
1.2 Classification of Subunit Vaccine
  1.2.1 EMEA Subunit Vaccine Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Subunit Vaccine Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Live Attenuated Vaccine
  1.2.4 Inactivated Vaccine
1.3 EMEA Subunit Vaccine Market by Application/End Users
  1.3.1 EMEA Subunit Vaccine Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospital
  1.3.3 Clinics
  1.3.4 Public Services
  1.3.5 Others
1.4 EMEA Subunit Vaccine Market by Region
  1.4.1 EMEA Subunit Vaccine Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Subunit Vaccine (2012-2022)
  1.5.1 EMEA Subunit Vaccine Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Subunit Vaccine Revenue and Growth Rate (2012-2022)

2 EMEA SUBUNIT VACCINE COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Subunit Vaccine Market Competition by Players/Manufacturers
  2.1.1 EMEA Subunit Vaccine Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Subunit Vaccine Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Subunit Vaccine Sale Price by Players (2012-2017)
2.2 EMEA Subunit Vaccine (Volume and Value) by Type/Product Category
  2.2.1 EMEA Subunit Vaccine Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Subunit Vaccine Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Subunit Vaccine Sale Price by Type (2012-2017)
2.3 EMEA Subunit Vaccine (Volume) by Application
2.4 EMEA Subunit Vaccine (Volume and Value) by Region
  2.4.1 EMEA Subunit Vaccine Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Subunit Vaccine Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Subunit Vaccine Sales Price by Region (2012-2017)

3 EUROPE SUBUNIT VACCINE (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Subunit Vaccine Sales and Value (2012-2017)
  3.1.1 Europe Subunit Vaccine Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Subunit Vaccine Revenue and Growth Rate (2012-2017)
3.2 Europe Subunit Vaccine Sales and Market Share by Type
3.3 Europe Subunit Vaccine Sales and Market Share by Application
3.4 Europe Subunit Vaccine Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Subunit Vaccine Sales Volume by Countries (2012-2017)
  3.4.2 Europe Subunit Vaccine Revenue by Countries (2012-2017)
  3.4.3 Germany Subunit Vaccine Sales and Growth Rate (2012-2017)
  3.4.4 France Subunit Vaccine Sales and Growth Rate (2012-2017)
  3.4.5 UK Subunit Vaccine Sales and Growth Rate (2012-2017)
  3.4.6 Russia Subunit Vaccine Sales and Growth Rate (2012-2017)
  3.4.7 Italy Subunit Vaccine Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Subunit Vaccine Sales and Growth Rate (2012-2017)

4 MIDDLE EAST SUBUNIT VACCINE (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Subunit Vaccine Sales and Value (2012-2017)
  4.1.1 Middle East Subunit Vaccine Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Subunit Vaccine Revenue and Growth Rate (2012-2017)
4.2 Middle East Subunit Vaccine Sales and Market Share by Type
4.3 Middle East Subunit Vaccine Sales and Market Share by Application
4.4 Middle East Subunit Vaccine Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Subunit Vaccine Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Subunit Vaccine Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Subunit Vaccine Sales and Growth Rate (2012-2017)
  4.4.4 Israel Subunit Vaccine Sales and Growth Rate (2012-2017)
  4.4.5 UAE Subunit Vaccine Sales and Growth Rate (2012-2017)
  4.4.6 Iran Subunit Vaccine Sales and Growth Rate (2012-2017)

5 AFRICA SUBUNIT VACCINE (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Subunit Vaccine Sales and Value (2012-2017)
  5.1.1 Africa Subunit Vaccine Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Subunit Vaccine Revenue and Growth Rate (2012-2017)
5.2 Africa Subunit Vaccine Sales and Market Share by Type
5.3 Africa Subunit Vaccine Sales and Market Share by Application
5.4 Africa Subunit Vaccine Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Subunit Vaccine Sales Volume by Countries (2012-2017)
  5.4.2 Africa Subunit Vaccine Revenue by Countries (2012-2017)
  5.4.3 South Africa Subunit Vaccine Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Subunit Vaccine Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Subunit Vaccine Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Subunit Vaccine Sales and Growth Rate (2012-2017)

6 EMEA SUBUNIT VACCINE MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 GE Healthcare Life Sciences
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Subunit Vaccine Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 GE Healthcare Life Sciences Subunit Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 GSK
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Subunit Vaccine Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 GSK Subunit Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Reber Genetics
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Subunit Vaccine Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Reber Genetics Subunit Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Merck
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Subunit Vaccine Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Merck Subunit Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Sanofi
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Subunit Vaccine Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Sanofi Subunit Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Virbac
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Subunit Vaccine Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Virbac Subunit Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Shenzhen Kangtai Biological Products
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Subunit Vaccine Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Shenzhen Kangtai Biological Products Subunit Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview

7 SUBUNIT VACCINE MANUFACTURING COST ANALYSIS

7.1 Subunit Vaccine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Subunit Vaccine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Subunit Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Subunit Vaccine Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA SUBUNIT VACCINE MARKET FORECAST (2017-2022)

11.1 EMEA Subunit Vaccine Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Subunit Vaccine Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Subunit Vaccine Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Subunit Vaccine Price and Trend Forecast (2017-2022)
11.2 EMEA Subunit Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Subunit Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Subunit Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Subunit Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Subunit Vaccine Sales Forecast by Type (2017-2022)
11.7 EMEA Subunit Vaccine Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Subunit Vaccine
Figure EMEA Subunit Vaccine Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Subunit Vaccine Sales Volume Market Share by Type (Product Category) in 2016
Figure Live Attenuated Vaccine Product Picture
Figure Inactivated Vaccine Product Picture
Figure EMEA Subunit Vaccine Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Subunit Vaccine by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Public Services Examples
Table Key Downstream Customer in Public Services
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Subunit Vaccine Market Size (Million USD) by Region (2012-2022)
Figure Europe Subunit Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Subunit Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Subunit Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Subunit Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure Africa Subunit Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Subunit Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Subunit Vaccine Sales Volume and Growth Rate (2012-2022)
Figure EMEA Subunit Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Subunit Vaccine Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Subunit Vaccine Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Subunit Vaccine Sales Share by Players (2012-2017)
Figure 2016 Subunit Vaccine Sales Share by Players
Figure 2017 Subunit Vaccine Sales Share by Players
Figure EMEA Subunit Vaccine Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Subunit Vaccine Revenue (Million USD) by Players (2012-2017)
Table EMEA Subunit Vaccine Revenue Share by Players (2012-2017)
Table 2016 EMEA Subunit Vaccine Revenue Share by Players
Table 2017 EMEA Subunit Vaccine Revenue Share by Players
Table EMEA Subunit Vaccine Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Subunit Vaccine Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Subunit Vaccine Sales Share by Type (2012-2017)
Figure Sales Market Share of Subunit Vaccine by Type (2012-2017)
Figure EMEA Subunit Vaccine Sales Market Share by Type (2012-2017)
Table EMEA Subunit Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Subunit Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Subunit Vaccine by Type in 2016
Table EMEA Subunit Vaccine Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Subunit Vaccine Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Subunit Vaccine Sales Share by Application (2012-2017)
Figure Sales Market Share of Subunit Vaccine by Application (2012-2017)
Figure EMEA Subunit Vaccine Sales Market Share by Application in 2016
Table EMEA Subunit Vaccine Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Subunit Vaccine Sales Share by Region (2012-2017)
Figure Sales Market Share of Subunit Vaccine by Region (2012-2017)
Figure EMEA Subunit Vaccine Sales Market Share in 2016
Table EMEA Subunit Vaccine Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Subunit Vaccine Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Subunit Vaccine by Region (2012-2017)
Figure EMEA Subunit Vaccine Revenue Market Share Regions in 2016
Table EMEA Subunit Vaccine Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Subunit Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Subunit Vaccine Revenue and Growth Rate (2012-2017)
Table Europe Subunit Vaccine Sales (K Pcs) by Type (2012-2017)
Table Europe Subunit Vaccine Market Share by Type (2012-2017)
Figure Europe Subunit Vaccine Market Share by Type in 2016
Table Europe Subunit Vaccine Sales (K Pcs) by Application (2012-2017)
Table Europe Subunit Vaccine Market Share by Application (2012-2017)
Figure Europe Subunit Vaccine Market Share by Application in 2016
Table Europe Subunit Vaccine Sales (K Pcs) by Countries (2012-2017)
Table Europe Subunit Vaccine Sales Market Share by Countries (2012-2017)
Figure Europe Subunit Vaccine Sales Market Share by Countries (2012-2017)
Figure Europe Subunit Vaccine Sales Market Share by Countries in 2016
Table Europe Subunit Vaccine Revenue (Million USD) by Countries (2012-2017)
Table Europe Subunit Vaccine Revenue Market Share by Countries (2012-2017)
Figure Europe Subunit Vaccine Revenue Market Share by Countries (2012-2017)
Figure Europe Subunit Vaccine Revenue Market Share by Countries in 2016
Figure Germany Subunit Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Subunit Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Subunit Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Subunit Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Subunit Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Subunit Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Subunit Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Subunit Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Subunit Vaccine Sales (K Pcs) by Type (2012-2017)
Table Middle East Subunit Vaccine Market Share by Type (2012-2017)
Figure Middle East Subunit Vaccine Market Share by Type (2012-2017)
Table Middle East Subunit Vaccine Sales (K Pcs) by Applications (2012-2017)
Table Middle East Subunit Vaccine Market Share by Applications (2012-2017)
Figure Middle East Subunit Vaccine Sales Market Share by Application in 2016
Table Middle East Subunit Vaccine Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Subunit Vaccine Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Subunit Vaccine Sales Volume Market Share by Countries in 2016
Table Middle East Subunit Vaccine Revenue (Million USD) by Countries (2012-2017)
Table Middle East Subunit Vaccine Revenue Market Share by Countries (2012-2017)
Figure Middle East Subunit Vaccine Revenue Market Share by Countries (2012-2017)
Figure Middle East Subunit Vaccine Revenue Market Share by Countries in 2016
Figure Saudi Arabia Subunit Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Subunit Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Subunit Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Subunit Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Subunit Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Subunit Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Subunit Vaccine Sales (K Pcs) by Type (2012-2017)
Table Africa Subunit Vaccine Sales Market Share by Type (2012-2017)
Figure Africa Subunit Vaccine Sales Market Share by Type (2012-2017)
Figure Africa Subunit Vaccine Sales Market Share by Type in 2016
Table Africa Subunit Vaccine Sales (K Pcs) by Application (2012-2017)
Table Africa Subunit Vaccine Sales Market Share by Application (2012-2017)
Figure Africa Subunit Vaccine Sales Market Share by Application (2012-2017)
Table Africa Subunit Vaccine Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Subunit Vaccine Sales Market Share by Countries (2012-2017)
Figure Africa Subunit Vaccine Sales Market Share by Countries (2012-2017)
Figure Africa Subunit Vaccine Sales Market Share by Countries in 2016
Table Africa Subunit Vaccine Revenue (Million USD) by Countries (2012-2017)
Table Africa Subunit Vaccine Revenue Market Share by Countries (2012-2017)
Figure Africa Subunit Vaccine Revenue Market Share by Countries (2012-2017)
Figure Africa Subunit Vaccine Revenue Market Share by Countries in 2016
Figure South Africa Subunit Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Subunit Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Subunit Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Subunit Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Table GE Healthcare Life Sciences Subunit Vaccine Basic Information List
Table GE Healthcare Life Sciences Subunit Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GE Healthcare Life Sciences Subunit Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure GE Healthcare Life Sciences Subunit Vaccine Sales Market Share in EMEA (2012-2017)
Figure GE Healthcare Life Sciences Subunit Vaccine Revenue Market Share in EMEA (2012-2017)
Table GSK Subunit Vaccine Basic Information List
Table GSK Subunit Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GSK Subunit Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure GSK Subunit Vaccine Sales Market Share in EMEA (2012-2017)
Figure GSK Subunit Vaccine Revenue Market Share in EMEA (2012-2017)
Table Reber Genetics Subunit Vaccine Basic Information List
Table Reber Genetics Subunit Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Reber Genetics Subunit Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Reber Genetics Subunit Vaccine Sales Market Share in EMEA (2012-2017)
Figure Reber Genetics Subunit Vaccine Revenue Market Share in EMEA (2012-2017)
Table Merck Subunit Vaccine Basic Information List
Table Merck Subunit Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck Subunit Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Merck Subunit Vaccine Sales Market Share in EMEA (2012-2017)
Figure Merck Subunit Vaccine Revenue Market Share in EMEA (2012-2017)
Table Sanofi Subunit Vaccine Basic Information List
Table Sanofi Subunit Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanofi Subunit Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Sanofi Subunit Vaccine Sales Market Share in EMEA (2012-2017)
Figure Sanofi Subunit Vaccine Revenue Market Share in EMEA (2012-2017)
Table Virbac Subunit Vaccine Basic Information List
Table Virbac Subunit Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Virbac Subunit Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Virbac Subunit Vaccine Sales Market Share in EMEA (2012-2017)
Figure Virbac Subunit Vaccine Revenue Market Share in EMEA (2012-2017)
Table Shenzhen Kangtai Biological Products Subunit Vaccine Basic Information List
Table Shenzhen Kangtai Biological Products Subunit Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Shenzhen Kangtai Biological Products Subunit Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Shenzhen Kangtai Biological Products Subunit Vaccine Sales Market Share in EMEA (2012-2017)
Figure Shenzhen Kangtai Biological Products Subunit Vaccine Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Subunit Vaccine
Figure Manufacturing Process Analysis of Subunit Vaccine
Figure Subunit Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Subunit Vaccine Major Manufacturers in 2016
Table Major Buyers of Subunit Vaccine
Table Distributors/Traders List
Figure EMEA Subunit Vaccine Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Subunit Vaccine Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Subunit Vaccine Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Subunit Vaccine Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Subunit Vaccine Sales Market Share Forecast by Region (2017-2022)
Table EMEA Subunit Vaccine Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Subunit Vaccine Revenue Market Share Forecast by Region (2017-2022)
Table Europe Subunit Vaccine Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Subunit Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Europe Subunit Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Subunit Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Subunit Vaccine Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Subunit Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Subunit Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Subunit Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Subunit Vaccine Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Subunit Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Africa Subunit Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Subunit Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Subunit Vaccine Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Subunit Vaccine Sales Market Share Forecast by Type (2017-2022)
Table EMEA Subunit Vaccine Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Subunit Vaccine Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


More Publications